Vertex Pharmaceuticals Inc (VRTX)

Interest coverage

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 3,832,000 3,877,000 3,965,600 4,045,500 4,307,400 4,151,600 4,079,400 2,935,200 2,782,100 2,809,311 2,514,538 3,391,079 3,174,949 2,961,237 2,286,724 1,790,058 1,453,421 838,894 909,167 803,048
Interest expense (ttm) US$ in thousands 44,100 45,100 47,900 51,300 54,800 58,300 59,855 60,733 61,511 62,699 61,300 59,693 58,151 56,112 56,804 57,770 58,502 62,997 67,135 70,453
Interest coverage 86.89 85.96 82.79 78.86 78.60 71.21 68.15 48.33 45.23 44.81 41.02 56.81 54.60 52.77 40.26 30.99 24.84 13.32 13.54 11.40

December 31, 2023 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $3,832,000K ÷ $44,100K
= 86.89

Interest coverage ratio is a financial metric used to evaluate a company's ability to meet its interest obligations on debt. It is calculated by dividing a company's earnings before interest and taxes (EBIT) by its interest expenses. A higher interest coverage ratio indicates that the company is more capable of servicing its debt.

In the case of Vertex Pharmaceuticals, Inc., the interest coverage ratio was not available for Q4 2023, Q3 2023, Q2 2023, and Q1 2023. However, in Q2 2022 and Q1 2022, the interest coverage ratios were 90.47 and 52.59, respectively. This indicates that Vertex Pharmaceuticals, Inc. had a strong ability to cover its interest expenses during those periods.

It is important to note that the absence of data for the most recent quarters makes it challenging to assess the current financial health of the company in terms of its ability to cover its interest expenses. Further analysis and monitoring of Vertex Pharmaceuticals, Inc.'s financial performance will be required to gain a more comprehensive understanding of its interest coverage ratio and overall financial stability.


Peer comparison

Dec 31, 2023


See also:

Vertex Pharmaceuticals Inc Interest Coverage (Quarterly Data)